TP53 and neoplasm: To test this, we generated mice heterozygous for Δ122p53 and a p53 mutant (mΔpro) that we previously described, that has attenuated tumor-suppressor activity.28, 29 The mΔpro mouse model is missing part of the p53 proline rich domain (PRD, amino acids 58–88).